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Primary open-angle glaucoma (POAG) is a hereditary neurodegenerative disease, characterized by optic nerve
changes including increased excavation, notching and optic disc hemorrhages. The excavation can be
described by the vertical cup–disc ratio (VCDR). Previously, genome-wide significant evidence for the associ-
ation of rs10483727 in SIX1–SIX6 locus with VCDR and subsequent POAG was found. Using 1000 genomes-
based imputation of four independent population-based cohorts in the Netherlands, we identified a missense
variant rs33912345 (His141Asn) in SIX6 associated with VCDR (Pmeta 5 7.74 3 10
27, n 5 11 473) and POAG
(Pmeta 5 6.09 3 10
23, n 5 292). Exome sequencing analysis revealed another missense variant rs146737847
(Glu129Lys) also in SIX6 associated with VCDR (P 5 5.09 3 1023, n 5 1208). These two findings point to SIX6
as the responsible gene for the previously reported association signal. Functional characterization of SIX6 in
zebrafish revealed that knockdown of six6b led to a small eye phenotype. Histological analysis showed retinal
lamination, implyinganapparentnormaldevelopmentof theeye,butan underdeveloped lens,andreducedoptic
nerve diameter. Expression analysis of morphants at 3 dpf showed a 5.5-fold up-regulation of cdkn2b, a cyclin-
dependent kinase inhibitor, involved in cell cycle regulation and previously associated with VCDR and POAG in
genome-wide association studies (GWASs). Since both six6b and cdkn2bplay a key role in cell proliferation, we
assessed the proliferative activity in the eye of morphants and found an alteration in the proliferative pattern of
retinal cells. Our findings in humans and zebrafish suggest a functional involvement of six6b in early eye devel-
opment, and open new insights into the genetic architecture of POAG.
INTRODUCTION
Primary open-angle glaucoma (POAG) is a neurodegenerative
disease (1) characterized by loss of retinal ganglion cells, optic
nerve degeneration, and as a consequence, visual field loss and
eventually blindness. It is recognized as a complex disease
in which multiple genetic and environmental factors interact
(2–4). Known risk factors include age, race, myopia, high
intraocular pressure (IOP), decreased central corneal thickness
and positive family history (1). First degree relatives of affected
individuals are estimated to have a 10-fold increased risk of
POAG compared with the general population (5). Heritability
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estimates of related quantitative traits as optic disc area (ODA),
vertical cup–disc ratio (VCDR), IOP and central corneal thick-
ness are high (52–59%; 48–80%; 35–42% and 68–72%,
respectively (6–9)).
Developments in the field of genomics have opened opportun-
ities to uncover the genetic mechanisms involved in POAG. To
date, at least 20 genetic loci have been linked to POAG, includ-
ing three causative genes (MYOC, OPTN, WDR36) (10–12). In
addition, genome-wide association studies (GWASs) have
allowed the identification of candidate genes, such as CAV1/
CAV2 (13,14), which are expressed in the trabecular meshwork
as well as in retinal ganglion cells, and TMCO1 which is also
expressed in retinal ganglion cells (15).
As in other disorders,GWASofPOAGhave targeted on endo-
phenotypes, i.e. heritable quantitative determinants of POAG.
This approach has facilitated the identification of genes that
were subsequently implicated in POAG. Three of the six loci
that have been associated with neurodegeneration of the optic
nerve (VCDR) (16) were also associated with POAG (17). The
strongest associations were seen for the single-nucleotide poly-
morphism (SNP) rs1900004, within 10 kb of the ATOH7 gene;
the rs10483727 near SIX1-SIX6 genes and the rs1063192, in
the 3′UTR region of CDKN2B gene.
Twoof these variants point to pathways involved in growth and
developmentof theoptic nerve.ATOH7andSIX1–SIX6genes are
transcription factors involved in eye development (18–22). The
roleofATOH7 ineyedevelopmentandretinalganglioncelldiffer-
entiation has been well characterized in several animal models
(18–20). SIX1 and SIX6 are homeoprotein members of the SIX/
sine oculis family of homeobox transcription factors (22). SIX1
is highly expressed in skeletal muscle (23) and has been involved
inmyogenesis (24),whileSIX6 ishighlyexpressed in thedevelop-
ingeye (25,26).Todate, it isnotclearwhichoneof the twogenes is
causally related toopticnervedegenerationandPOAG,asking for
a more in-depth analysis of the SIX1–SIX6 region.
The protein encoded by CDKN2B gene, the third POAG gene
identified by GWAS of VCDR, has emerged as a key protein in
the pathogenesis of optic nerve degeneration andPOAG in differ-
ent populations (15–17,27–33). CDKN2B gene is a member of
the family of cyclin-dependent kinase (CDK) inhibitors which
play a role in cell cycle regulation, influencing the proliferation/
differentiation balance (34). In the Six6 null mice it was demon-
strated that Six6 repress the transcription of members of the
Cdkn1 family, particularly Cdkn1b (35). Therefore, it may be
speculated that the SIX1–SIX6 region is potentially related to
the CDKN2B regulation, although this has not been described.
In this study, we investigated the SIX1–SIX6 locus in depth in
human and zebrafish. First, we fine-mapped the region and per-
formed a conditional, and exome sequencing analysis. As we
found two variants that pointed to SIX6 as best candidate gene,
we next characterized the effect of six6b knockdown on eye de-
velopment of zebrafish and evaluated expression levels of
several target genes in morphants, including cdkn2b.
RESULTS
Fine mapping of the SIX1–SIX6 region
The results of the analyses in the Rotterdam Study (RS) and the
ErasmusRucphenFamily (ERF) study are shown inTable 1. The
IOP analysis included 5782 (RS-I), 2116 (RS-II), 2038 (RS-III)
and 2589 (ERF) participants. The optic nerve head analyses
included 5322 (RS-I), 2054 (RS-II), 1966 (RS-III) and 2131
(ERF) participants with reliable data. The case–control studies
consisted of 188 cases and 5548 controls from the RS-I and
104 cases and 2126 controls from the GRIP/ERF study.
Fine mapping of the SIX1–SIX6 region based on imputations
of the SNPs using 1000 Genomes Project revealed a missense
variant rs33912345 in SIX6, this variant is in complete linkage
disequilibrium with the previous reported intergenic variant
rs10483727 (the two D’ and r2 ¼ 1). Both the rs10483727 and
the missense variant in SIX6 rs33912345 were associated with
VCDR (Pmeta ¼ 5.56 × 1027 and 7.74 × 10207, respectively),
ODA (Pmeta ¼ 1.69 × 1023 and 3.51 × 1023, respectively) and
POAG (Pmeta ¼ 2.95 × 1023 and 6.09 × 1023, respectively)
(see Table 1). The significant association between rs10483727
and VCDR disappeared after adjustment for rs33912345
(Pmeta ¼ 8.72 × 1021), indicating that the SIX6 variant is most
likely responsible for the association. This variant determines
an amino acid change (His141Asn) in the homeobox DNA-
binding domain of SIX6. PolyPhen-2 (36) predicted a benign
effect (score ¼ 0) for this evolutionarily conserved variant,
based on the Genomic Evolutionary Rate Profiling (GERP)
(37) score ¼ 5.38. No significant association was found with
variants in SIX1.
Exome sequencing of SIX1–SIX6 region
To determine whether there were other unobserved rare variants
in SIX6, we explored the presence of exonic variants associated
with VCDR in this region. In exome sequence data from 1208
individuals of the ERF study, we found another missense
variant, rs146737847 (MAF ¼ 0.0023), in SIX6 (P ¼ 1.25 ×
1023). This evolutionarily conserved variant (GERP ¼ 5.38)
determines an amino acid change (Glu129Lys) in the homeobox
DNA-binding domain of SIX6, which PolyPhen-2 predicted as
probably damaging (score ¼ 0.971). When conducting a con-
ditional analysis on rs33912345, the rs146737847 variant
remained associated with VCDR (P ¼ 4.58 × 1023), con-
firming that both variants are independent of each other. Direc-
tion of the effect of both variants was the same; rs33912345
(b ¼ 0.011, se ¼ 0.002) and rs146737847 (b ¼ 0.183, se ¼
0.055). No exonic variants in SIX1were significantly associated
with VCDR
eQTL and expression analyses
No significant cis or trans-eQTLs effects for rs10483727,
rs33912345 or rs14673784were found in theGTExproject data-
base (38). The Ocular Tissue Database (39) was used to com-
pared the expression levels of SIX1 and SIX6 in different
human ocular tissues. We found that SIX6 is highly expressed
in relevant tissues for POAG, including cornea, optic nerve, tra-
becular meshwork and retina, compared with SIX1 (PLIER
number 27.33 versus 9.65; 22.25 versus 18.32; 25.80 versus
15.43 and 26.08 versus 14.73; respectively).
Exclusionof aneQTLeffect of the evaluatedSNPson thegene
expression of SIX1 or SIX6, together with the fine-mapping and
exome sequencing data, suggests that the variants in SIX6 rather
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than SIX1 explain the observed association signal reported in
previous studies in the region.
Identification and characterization of zebrafish six6b
A zebrafish six6 ortholog was retrieved from the Ensembl data-
base. Two genes were found, six6a and six6b. The protein
encoded by six6a together with the protein encoded by six6b
was blasted against the human SIX6 protein, showing that
six6a and six6b independently have 91% identity to the human
SIX6, while the overall identity of both zebrafish six6 to the
human protein is 88% (Supplementary Material, Fig. S1). In
this study, we evaluated the effect of six6b depletion.
To evaluate the role of six6b at different time points of the de-
velopment, a quantitative reverse transcription PCR (RT-qPCR)
was performed. Taking reference expression levels at 1 day post
fertilization, we found that over time expression of six6b grad-
ually increases, reaching a peak at the larvae stage of 3 dpf,
then decreasing at 5 dpf (Fig. 3A).
six6b is required for normal eye development in zebrafish
To evaluate the function of six6b during embryonic develop-
ment, two non-overlapping antisense MOs were designed, the
first one targeting the AUG translation initiation site (six6b
AUG-MO) and the other targeting the exon1/intron1 splice site
(six6b SB-MO). Since embryos injected with either six6b
AUG-MO or six6b SB-MO developed similar dose-dependent
(2–12 ng) small eye size compared with controls, the six6b
SB-MO (6 ng) was selected for further studies as it provided
the possibility of quantifying the efficiency of knockdown by
RT-qPCR. Embryos injected with the highest concentration of
the MOs (12 ng) showed a severe phenotype (twisted trunk,
small head and eye, massive heart edema and lethality at
4 dpf, data not shown).
Eye size difference between injected and control embryoswas
quantified at 5 dpf since the phenotype is then well defined and
easy to evaluate (Fig. 1A). Seventy-eight percent of the injected
embryos showed a small eye phenotype (n ¼ 286). RT-qPCR
analysis indicated six6b SB-MO reduced six6b mRNA levels
by 70% (Supplementary Material, Fig. S2). To elucidate
whether morphants showed small eye phenotype secondary to
six6bknockdownas opposed to an overall delay in development,
we measured the ratio of the eye size to body length (E:B) (40).
The E:B ratio was measured in 30 embryos of each group
(Fig. 1B). Morphants showed small eyes compared with con-
trols, suggesting an eye development delay (mean E:B ¼
0.064 versus 0.092, P ¼ 4.96 × 10220). Other abnormalities
were observed as pericardial edema, diffuse pigmentation that
resembles an expanded melanophore phenotype, small head,
and in some embryos short jaw. To exclude the presence of
small head as a principal cause of a small eye, we measured
the ratio of the eye size to head length (E:H) in 30 embryos
of each group (i.e. wild-type (WT), six6b SB-MO injected and
six6b SB-MO + p53-MO co injected). This measure provides
the possibility of evaluating the impact of six6b knockdown on
eye size independent of the head size reduction. The E:H ratio
was significantly smaller in morphants compared with WT
embryos (mean E:H ¼ 0.445 versus 0.530, P ¼ 2.59 × 10210;
Supplementary Material, Fig. S3).T
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We performed two control experiments; first, a specific
p53-targeting MO (4 ng) was co-injected with the six6b
SB-MO (6 ng) to exclude whether the phenotype observed was
due to off-target effects mediated by induction of p53 expres-
sion. The mean ratio E:B in p53-MO co-injected embryos was
0.061, showing a small eye phenotype comparable with six6b
knockdown (P ¼ 2.41 × 10231). Excluding a small eye size as
a consequence of p53-mediated apoptosis pathway. Second,
we conducted rescue experiments using WT six6b mRNA.
Since no difference in the body length was observed between
WT and morphants at 5 dpf (mean ¼ 3.952 mm versus
3.908 mm, respectively; P ¼ 1.95 × 1021), assessment of
rescue experiments was focused on eye dimensions only.
Co-injection of six6b SB-MO with wt-six6b mRNA resulted in
a partial, but significant, rescue of small eye phenotype (mean
eye area improved from 1.425.747to 1.749.203 mm2, P ¼ 1 ×
1023; Fig. 1C and Supplementary Material, Fig. S4).
Loss of six6b results in immature and underdeveloped eyes
In order to carry out detailed assessment of the six6b SB-MO
small eye phenotype, histological analysis was performed on
embryos at 3 and 5 dpf (Fig. 2A–G). Histology revealed that
retinal lamination in morphants occurred. Therefore, the gan-
glion cell layer (GCL), inner nuclear layer (INL), and outer
nuclear layer (ONL)were visualized byH&Estaining.Although
the optic nerve was seen leaving the retina, its thickness was
decreased compared with WT embryos. A semi-quantitative
analysis on serial sections of six microns showed that the optic
nerve thickness on WT embryos (n ¼ 4) was around 21 mm,
while in morphants (n ¼ 4) it was 12 mm. In addition, the
lens of 3 dpf morphants was immature and cellularized com-
paredwith controls of the same age, supporting that eyes ofmor-
phants were delayed in development. Eyes ofmorphants at 5 dpf
showed a conserved general architecture, leaving small size as
Figure 1. Phenotype characterization of six6b SB-MO injected fish. (A) six6b knockdown results in a small eye phenotype, other abnormalities including pericardial
edema, diffused pigmentation small head and short jaw were also observed. The small eye phenotype was not rescued after co-injection with p53-MO indicating a
specific effect of six6b SB-MO on eye size. (B) Ratio of eye to body size (E:B) in morphants and p53 co-injected compared with WT embryos, n ¼ 30 for each
group.P-values are indicated in the text. (C)Co-injectionofwt six6bmRNAand six6bSB-MOpartially rescued the small eyephenotype.Themean eyearea improves
from 1.425.747 to 1.749.203 mm2, P ¼ 0.001.
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the principal difference between control embryos andmorphants
at this age.
Immunohistochemical localization of six6 was studied using a
rabbit anti-SIX6 polyclonal antibody on sections at 3 and 5 dpf
(Fig. 2B–H). Since the rabbit anti-SIX6 can recognize the
protein products of the closely related six3a and six3b as well,
the anti-SIX6 immunoreactivity was only used to investigate the
localizationof six6/3proteins in the zebrafish retina, not for the ef-
ficiency of six6b knockdown. BothWT andmorphants were ana-
lyzed. Consistent with previous studies in chick embryos, mouse,
and human fetal and adult eye (21,22,41–43), we found six6/3
protein localized in the nuclei of the GCL, the nuclei of potential
bipolar, amacrine and horizontal cells located in the INL, the
nuclei of the photoreceptors and the optic nerve (Fig. 2B–F).
In general, labeling in WT embryos at 3 dpf was stronger than
at 5 dpf. Morphants at 3 dpf presented less intense labeling, as
predicted from expression data.
Expression patterns of six3a and six3b in six6bmorphants
TheSIXgene familyofhomeoproteins is required inbothDrosoph-
ila and vertebrates for eye development. Similar to SIX6, SIX3 has
also been involved in eye development (26,44–46), both genes
share high homology and are expressed during early stages
(21,25). To determine whether zebrafish six3 can compensate
six6b depletion, RT-qPCR of morphants at 3 dpf was performed.
Two orthologs of the human SIX3 were retrieved from Ensembl,
six3a (ENSDARG00000058008) and six3b (ENSDARG0000
0054879). RT-qPCR of morphants compared with WT showed
an expected down-regulation of six6b. Surprisingly, we found
down-regulation of six3a in morphants as well, while expression
levels of six3b were not significantly deregulated (Fig. 3B).
Knockdown of six6b up-regulate expression of the cell cycle
inhibitor cdkn2b in zebrafish
Since Six6/Dach interacts with some members of the family of
cyclin-dependent kinases (CDK) inhibitors (35), we decided to
evaluate whether knockdown of six6b in zebrafish alters the ex-
pression of cdkn2b, another member of the CDK inhibitors pre-
viously associated in our GWAS studies with VCDR (16) and
POAG (17). RT-qPCR was performed at 3 dpf on injected and
WT embryos, showing a 5.5-fold overexpression of cdkn2b
in morphants compared with WT (P ¼ 1.56 × 10202), while
cdkn2c and cdkn2d (taken as a control) remain unaffected
(Fig. 3C). Expression levels of dacha and dachb at 3 dpf
showed no differences between morphants and controls (data
not shown).
Effect of six6b knockdown on cell proliferation
in the developing eye of zebrafish
To evaluate whether up-regulation of cdkn2b inmorphants leads
to premature cell cycle exit, we examined the expression of the
proliferating cell nuclear antigen (PCNA) in eye by immunos-
taining. WT embryos and morphants at 2, 3, 4 and 5 dpf were
analyzed.
InWTfishat 2 dpf, almost all retinal progenitor cells showeda
strong PCNA immunoreactivity (Fig. 4A). As expected, in WT
embryos at 3, 4 and 5 dpf, cells concentrated in the ciliary
marginal zone were PCNA-positive (Fig. 4B–D). The ciliary
marginal zone is a proliferative zone described in eye of cold-
blooded vertebrates (47). Thus, this finding is consistent with
normal retinal differentiation processes in zebrafish (48,49). In
contrast, morphants at 3 and 4 dpf showed numerous PCNA-
Figure2. six6bknockdownresults in small andunderdevelopedeyes. (A–D)Representative imagesofhistological sectionsofWT(AandB)andmorphants (CandD)
at 3 dpf.Though retinal laminationoccurred inmorphants, note the cellularized andunderdeveloped lens. Panels (A) and (C)were hematoxylin–eosin (H&E) stained.
(E–H)Histological sections ofWT (EandF) andmorphants (GandH) at 5 dpf.Note that at this age small eye sizewas the principal differencebetween thegroups, the
lens of morphants resembles theWT lens. Panels (B, D, F and H) show immunohistochemical localization of six6/six3 in bothWT andmorphants. The optic nerve is
marked by arrowheads; L ¼ Lens.
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positive cells in the photoreceptor and inner nuclear layers
(Fig. 4F and G), suggesting that proliferation in morphants was
not restricted to the ciliary marginal zone; on the contrary,
retinas of morphants at 3 and 4 dpf showed a PCNA immunor-
eactivity pattern that resembled 2 dpfWT retinas. At 5 dpf mor-
phants showed PCNA immunoreactivity mostly restricted to the
ciliary marginal zone comparable with WT embryos (Fig. 4H).
We also investigated whether increased apoptosis was the
cause of small eye phenotype. Caspase-3 staining did not show
an increased apoptosis rate in morphants compared with WT
embryos (Supplementary Material, Fig. S5).
DISCUSSION
In this study, we investigated the SIX1–SIX6 region in more
detail to understand its role in optic nerve degeneration. Fine
mapping and conditional analysis revealed a missense variant,
rs33912345, in the SIX6 gene. Further analysis of the
SIX6 exonic region revealed another rare missense variant,
rs146737847. Both variants are located in the homeobox DNA-
bindingdomainofSIX6 and are highly evolutionarily conserved.
No common or rare variants in SIX1 were significantly asso-
ciated to VCDR or POAG.
In line with previous findings, the rs33912345 has been
described in patients with severe eye malformations, including
anophthalmia, microphthalmia and coloboma (22,50,51). It is
in complete linkage disequilibrium with the reported SNP
rs10483727, which is known to be associated with VCDR and
POAG (16,17,30). The rs146737847 variant has been reported
in POAG cases of United States at the American Society of
Human Genetics meeting 2012 (http://www.ashg.org/2012m
eeting/abstracts/fulltext/f120122353.htm).
SIX6 in adult human tissues is highly expressed in the choroid,
ciliary body, sclera, optic nerve head and retina, particularly
GCL, INL and ONL (43). Mouse, chick and Xenopus studies
have demonstrated a role of Six6 during eye development
(22,26,35,52), whereas Six1 is highly expressed in skeletal
Figure 3. six6, six3a/six3b and cdkn2bmRNAexpression change. (A)WT relative expression of six6b, six3a and six3b over time from1 to 5 dpf. Relative expression
was calculated by setting the 1 dpf expression level at 1. Samples expression were normalized to the control gene b-actin (B) six6b knockdown in response to six6b
SB-MO at 3 dpf. In addition, morphants showed downregulation of six3a but no six3b (C) Overexpression of cdkn2b in response to six6b depletion. All sample
expression from experiments B and C were normalized to the control gene sdha. Relative expression was calculated by setting the WT expression level at
1. Values represent means+ s.e.m. ∗P , 0.05; ∗∗P , 0.01.
Human Molecular Genetics, 2014, Vol. 23, No. 5 1325
 at Institute of Social Studies on M
ay 17, 2016
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
muscle (23) and plays a role in myogenesis (24). Both our find-
ings and the known biological function support the notion that
SIX6, rather than SIX1, may play a role in VCDR and POAG.
To evaluate the function of the SIX6 gene on eye development
and POAG.Weused zebrafish as animalmodel due to its numer-
ous advantages in comparison to mammalian models (53). We
assessed the effect of six6b knockdown in zebrafish. Deficiency
of six6b in zebrafish led to a small eyephenotype, associatedwith
small head and pericardial edema. Although morphants showed
a small head,we found that the eye ofmorphants remains smaller
independently of the head size. Other abnormalities, including
diffused pigmentation were also observed. A clear connection
between the visual system, particularly retinal-hypothalamic
projections, and the control of pigment cells has been established
(54–56). In this study, six6b depleted embryos showed diffused
pigmentation, a feature present inmutantswho lack the ability to
sense ambient light (57). This may indicate an abnormal eye
function in six6b morphants. Furthermore, histological sections
of six6b morphants at 3 dpf showed a rudimentary lens, which
indicates a developmental delay of the eye. Also, the optic
nerve had a reduced thicknesswhen comparedwith age-matched
controls, which is relevant in the context of the neurodegenera-
tive disease POAG. This finding is consistent with previous ana-
lysis of Six6 null mice (35), which showed retinal hypoplasia,
with often absence of optic nerve and chiasm. All these results
support our hypothesis that the main effect of six6b knockdown
is in the ocular system.
In flies, sine oculis (so) andOptix play a central role in eye de-
velopment (25,58). In vertebrates, the Six3 and Six6 are the
homologs of Optix. Both the Six3 and Six6 show high homology
and are expressed during early stages of eye development
(25,26). Six3 has a wide role in forebrain development,
whereas Six6 has a more specific role in eye development
(35,45,46,52,59–61). We evaluated the effect of six6b knock-
down on expression levels of six3a and six3b. No significant
changes in expression levels of six3b were found in morphants
compared with WT embryos. Interestingly, we found down-
regulationof six3a in six6bmorphants.However, 14mismatches
between the six6b SB-MO and the six3a gene confirmed that our
MOdid not target six3a. Down-regulation of six3a in six6bmor-
phants might suggest a complex feedback mechanism between
six3a/six3b and six6b in zebrafish. Though both Six3 and Six6
might function through similar (62) and different (63) mechan-
isms, our results show that in zebrafish six6b is needed for
normal eye development. Neither six3a nor six3b can compen-
sate for six6b deficiency, resulting in a small eye phenotype.
Studies in medaka fish indicate that Six3 and the replication–
initiation inhibitor gemini act antagonistically to regulate the
balance between proliferation and differentiation during eye de-
velopment (62). Six6 also interacts with gemini (62), supporting
a potential role of Six6 in cell proliferation and differentiation.
Additionally, in the Six6 null mice it was demonstrated that
Six6 interacts withDach1, a transcriptional co-repressor, to sup-
press Cdkn1b transcription in vivo (35). Cdkn1b is a member of
theCDK inhibitor family and controls the cell cycle progression,
arresting cell proliferation. CDKN2B, a gene known to be asso-
ciated with VCDR and POAG (16,17,27,28,30,64), is also a
member of theCDK inhibitor family.CDKN2B controls G1 pro-
gression of the cell cycle and is highly induced by TGF-b (65),
which in turn is one of the pathways involved in POAG patho-
genesis (17). We demonstrated a 5.5-fold overexpression of
cdkn2b in six6b morphants compared with WT embryos. This
finding is in accordance with a rat model of glaucoma (15), in
which overexpression of Cdkn2b was described after induction
of high IOP. Up-regulation of cdkn2b arrests cell cycle progres-
sion causing an abnormal proliferation and small eye phenotype.
Figure4. six6b is involved inproliferationanddifferentiationof retinal cells in zebrafish. (A–D)Representative imagesofPCNAimmunoreactivity inWTembryosat
2, 3, 4 and 5 dpf; (A) InWTembryos at 2 dpf almost all cellswerePCNA-positive, the lenswas cellularized and therewas not retinal lamination,while at 3, 4 and 5 dpf
(B–D) proliferation is restricted to the ciliarymarginal zone,markedby arrowheads. Retinal lamination is clear and the lens ismature and not cellularized. In contrast,
morphants at 3 and 4 dpf present proliferating cells located outside the ciliary marginal zone (F andG). Note that at 5 dpf the morphants resembles the WT retina,
although some cells located in the central retinal showed a positive PCNA signal (H).
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Based on our results, we conclude that Six6 repress the expres-
sion not only of Cdkn1b, as previously reported (35), but also
cdkn2b. This reveals a new interaction between the two known
pathways associated with POAG (developmental and TGF-b
signaling pathways) (Fig. 5A; www.ingenuity.com).
Next, we evaluated the proliferative activity of retinal cells
through PCNA assessment. PCNA allows detection of cells
in either G1 or S phase of the cell cycle. We found that knock-
down of six6b changes the pattern of positive PCNA labeling.
Similar results were found in a previous study, in which a col-
lagen gene (drCol15a1b)was knockdown in zebrafish (66). It is
well established that retinal progenitor cells start a differenti-
ation process when they exit the cell cycle (66,67). Analysis
of drCol15a1bmorphants indicated that cells arrested in a pro-
liferative state were undifferentiated (66). Our results demon-
strate an abnormal proliferation in the presence of an efficient
knockdown of six6b with a recovery at 5 dpf. This could be
explained by a reduced morpholino activity, as a consequence
of its dilution due to cell growth anddivision.Based onourfind-
ings, we hypothesized that decreased expression of six6b may
lead to fewer differentiated cells as depicted by our proposed
model in Figure 5B. This needs to be assessed in future studies
by evaluating the presence of retinal-differentiated cells in the
eyes of six6b morphants. Caspase-3 assessment did not show
an increased number of apoptotic cells in the eye of six6b-
depleted embryos.
In conclusion, by combining fine-mapping and exome se-
quence analysis we found that SIX6, rather than SIX1, is respon-
sible for the association signal previously reported in the SIX1/
SIX6 region.We found two variants located in theDNA-binding
homeodomain of SIX6, whichwere significantly associatedwith
VCDR. The rs33912345 variant was also associatedwith POAG
in our study. Knockdown of six6b in zebrafish led to a small eye
phenotype, as a result of an abnormal proliferative pattern in
retinal cells. This alteration may also be associated with a dis-
turbance in the differentiation process of retinal progenitor
cells. Additionally,wewere able to find an in vivo interaction be-
tweenproteins identifiedby theGWAS(SIX6andCDKN2B) for
POAG. Further biological research is needed to verify the exact
mechanism behind this interaction. Our findings from genetic
association and functional studies demonstrate that SIX6 is a
susceptibility gene for POAG and is involved in early eye devel-
opment. This study provides new insight into the complex
genetic architecture of POAG.
MATERIALS AND METHODS
Human and fine-mapping studies
Study populations
The RS is a prospective cohort study in the district Ommoord of
Rotterdam. The rationale and study design are described else-
where (68). The original cohort (RS-I) consisted of 7983 resi-
dents aged ≥55 years. In 2000, the cohort was extended with
3011 residents aged ≥55 years (RS-II). In 2006, the cohort
was further expanded with 3932 residents aged 45–54 years
(RS-III). Details about examinations in each one of the cohorts
are described elsewhere (16).
Figure 5. six6b and cdkn2b interaction. (A) Ingenuity diagram of the biological interaction of the known genes identified through the GWASof optic disc parameters
(VCDR, ODA and IOP); the bold dashed line shows the new interaction found in this study using a zebrafish model. The Ingenuity knowledge base is a repository of
biological interactions and functional annotations of in vivo and in vitro experiments (www.ingenuity.com). The diagramwas generated using the function ‘Path Ex-
plorer’. (B) six6b represses cdkn2b transcription in association with the co-represor dach. six6b and dach form a complex that interacts with the regulatory region of
cdkn2b. This interaction blocks cdkn2b transcription and thus controls the proliferative state of retinal progenitor cells. VCDR, vertical cup–disc ratio; ODA, optic
disc area; IOP, intraocular pressure.
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The ERF Study is a family-based study in a genetically iso-
lated population in the southwest of the Netherlands. It includes
over 3000 participantswith age varying between 18 and 86 years
old. The cross-sectional examinations took place between 2002
and 2005. The rationale and study design have been described
elsewhere (69,70).
An independent series of 104 glaucoma cases froman isolated
population (the Genetic Research in an Isolated Population
[GRIP] study) was used for a case–control analysis. These
patientswere recruited in three local hospitals in the geographic-
al region of the ERF study. They did not participate in the ERF
study. Participants from the ERF study were used as the
control population.
Ophthalmic examinations
The ophthalmic assessment in the RS and ERF study included a
medical history, autorefraction, keratometry, IOP measure-
ments, visual field testing, fundus photography and optic nerve
head imaging. Details about IOP and optic disc measurements
are described elsewhere (16,71). In RS-I, glaucoma diagnosis
was based on glaucomatous visual field loss (GVFL). The
visual field of each eye was screened using a 52-point supra-
threshold test that covered the central visual field with a radius
of 248, and that tested the same locations as used in theGlaucoma
Hemifield Test. Participants with a reproducible visual field loss
in a second supra-threshold test, were evaluated with a Gold-
mann kinetic perimetry or full-threshold HFA test by a skilled
perimetrist on both eyes. We incorporated prevalent glaucoma
cases, (72) as well as incident cases (73) based on GVFL
during at least one of the examination rounds. VCDR per se
was not an inclusion criteria of the diagnosis. In GRIP/ERF,
the diagnosis was based on the optic disc appearance, visual
field testing and angle assessment.
The study protocols were approved by the Medical Ethics
Committee of the Erasmus University, and all participants
have given a written informed consent in accordance with the
Declaration of Helsinki.
Genotyping and statistical analyses of fine-mapping studies
Illumina Infinium IIHumanHap550 chip v3.0 arraywas used for
DNA genotyping in RS-I, RS-II and RS-III. In the ERF study,
genotyping was performed using Illumina 318 K, Illumina
370 K, Illumina 610 K and Affymetrix 250 K genotyping plat-
forms. Imputation for both studies was done by using 1000
Genomes Phase 1 (v3) as the reference.
We used the mean IOP, VCDR or ODA of both eyes. In cases
ofmissing or unreliable data on one eye, the other eyewas taken.
Participants with a history of glaucoma laser or surgery were
excluded for the IOP analysis. IOPmeasurements of participants
with IOP lowering medication were imputed by adding 25% to
the value of the measurement. We used 1000 Genomes Phase
1(v3) to perform fine mapping and modeling of SIX1/SIX6
locus in relation to these continuous outcomes on an assumed
additive model for the effect of the risk allele. Additionally,
we examined through logistic regression the association
between the SIX1/SIX6 locus and primary open-angle glaucoma.
All analyses were adjusted for age, sex, the first two principal
components (RS) or family structure (ERF). Extra adjustments
were done with spherical equivalent, as a measure of myopia,
to evaluate whether the missense variant rs33912345 was
independently associated with VCDR. The spherical equivalent
was calculated for each eyeusing the standard formula: spherical
equivalent ¼ sphere + 1/2 cylinder. Additionally, independ-
ence between rs10483727 and rs33912345 was tested, adjusting
for the last one. Then, an inverse variance weighted meta-
analysis was performed.
Exome sequencing
Exomes of 1309 individuals from the ERF population were
sequenced ‘in-house’ at the Center for Biomics of the Cell
Biology department of the Erasmus MC, The Netherlands,
using the Aligent version V4 capture kit on an Illumina
Hiseq2000 sequencer and the TrueSeq Version3 protocol. The
sequences reads were aligned to the human genome build 19
(hg19) using Burrows-Wheeler Aligner (74) and NARWHAL
pipeline (75). For each sample, at least 4 Gigabases of sequence
was aligned to the genome with an average fold-coverage of
74.23x per base. Subsequently, the aligned readswere processed
further using the Indel Realigner, Mark Duplicates and
Table Recalibration tools from the Genome Analysis Toolkit
(GATK) (76) and Picard (http: picard.sourceforge.net) to
remove systematic biases and to recalibrate the PHRED
quality scores in the alignments. Genetic variants were called
using theUnifiedGenotyper Tool fromGATK.Of the 1309 indi-
viduals, 1208 had data on VCDR. As the ERF study included
related individuals, association analysis was performed in
SOLAR using procedure ‘polygenic –screen’, and adjusting
for age and sex. In total, two variants in SIX1 and seven variants
inSIX6with a call rate of.0.99were found.Onlyone of the nine
variants at SIX6, rs146737847, reached significance levels. In
addition, conditional analyses were performed with the
rs33912345, previously found in the fine-mapping analysis.
eQTL and expression analyses
We used the Genotype-Tissue expression (GTex) project data-
base (www.broadinstitute.org/gtex/) to examine whether
rs10483727, rs33912345 or rs146737847 had a cis- or trans-
eQTL effect. Although the GTex database does not include
eye tissues, it contains more than 10 different brain regions
and other tissues. For trans-eQTL analysis, a P-value of 5 ×
10213 was considered significant (38).
Additionally, we compared expression levels of SIX1 and
SIX6 using the Ocular Tissue Database (https://genome.uiowa.
edu/otdb/). The gene expression is indicated as Affymetrix
Probe Logarithmic Intensity Error (PLIER) number. The
PLIER numbers were calculated by GC-background correction,
PLIER normalization, log transformation and z-score calcula-
tion (39). Larger PLIER numbers represent high expression
levels of a particular gene in particular tissue.
Statistical analysis of zebrafish experiments
Statistical analysiswas performed usingSPSS statistics 20.Ana-
lysis of E:B and E:H ratios was performed using the Student’s
t-test. Each group (six6b SB-MO injected, p53 MO injected
and six6b SB-MO + p53 MO co-injected) was compared indi-
vidually with the WT group (n ¼ 30, in each group). All
RT-qPCR experiments were undertaken in triplicate. Results
were considered statistically significant when P , 0.05, and
are denoted in the figures with an asterisk.
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Zebrafish maintenance
The zebrafish (Danio rerio) strain used for this work was the
Tupfel long fin (TL). Adults were maintained at 288C on a
14 hour-light/10 h dark cycle. Embryos were collected from
natural mating and raised in system water containing methyl-
ene blue at 288C. Developmental stages were determined
according to Kimmel (77). All procedures and conditions
were in accordance with the Dutch animal welfare legislation.
The use of zebrafish for this study was approved by the Institu-
tional Review Board for experimental animals of the Erasmus
MC, Rotterdam.
Genetic analysis of the zebrafish SIX6 ortholog
The zebrafish six6 ortholog was retrieved from Ensembl using the
comparative genomics tool (78). Two genes were found, six6a
(ENSDARG00000025187) and six6b (ENSDARG00000031316).
In this study, we reported the effect of six6b knockdown. We
sequenced WT zebrafish six6b to corroborate the reference se-
quence and select the regions for morpholino oligonucleotide
(MO) design.
Morpholino and mRNA microinjections
Morpholino antisense oligonucleotides were obtained from
Gene-Tools (Philomath, OR, USA). Two morpholinos were
designed against six6b. One morpholino was designed to target
the translation initiation site: AUG-MO ¼ 5′-AAATTGG
CAACTGAAACATGAAGGC-3′; and the second morpholino
targeted exon 1 donor site: SB-MO ¼ 5′-TGTAAATCTGGAA
AACGCACCTGTT-3′. All MO sequences were aligned with
the Danio rerio genome using NCBI and UCSC Blast to
confirm specificity to the six6b genomic region and ratify that
neither the AUG-MO nor the SB-MO recognized six6a, six3a
or six3b. Apreviously describedMOdesigned to target the trans-
lation site of p53 (p53-MO ¼ 5′-GCGCCATTGCTTTGC
AAGAATTG-3′ was used for control experiments (79). Mor-
pholinos were reconstituted in distilled water and further
diluted in Danieau solution containing 0.1% Phenol Red for
microinjections into embryos.
Indicated dosages ofMOswere injected into the yolk of one to
two cell stage using a pneumatic picopump (World Precision
Instruments, Berlin, Germany). Optimum dose was considered
when maximal knockdown efficiency, low mortality rate and
small eye phenotype without severe malformations were
observed on injected embryos. Six nanograms of either SB or
AUG-MO were selected as optimal concentration. In separate
experiments, 4 ng of p53-MO was co-injected with 6 ng of
six6b-specific MO (SB or AUG), in order to detect off-target
effects due to activation of p53 expression.
ForMOrescue experiments,WTDanio rerio six6b cDNAwas
ligated into the pCR2.1-TOPO vector (Invitrogen), and sub-
cloned at the site of EcoRI in pCS2+ vector. The fidelity of
six6b-pCS2was verified bydirect sequencing.Using as template
NsiI linearized six6b-pCS2, WT six6b mRNA was synthesized
using a mMESSAGE mMACHINE SP6 kit (Ambion Inc).
Double injection of mRNA and MO was carried out in two
steps, first 3 ng six6b SB-MO were injected into the yolk, then
a second injection with 9 pg six6b mRNA into the cell was per-
formed, all embryoswere injected in one-cell stage. Eye sizewas
evaluated at 3 dpf.
RNA isolation and RT-qPCR
Pooled embryoswere snap frozen in liquid nitrogen and stored at
2808C. Total RNA from 60WT embryos at 1,2,3,4 and 5 dpf
was isolated for time series analyses. For evaluation of six6b
knockdown, total RNA was isolated from 60 morphants and
WT embryos at 3 dpf; in all extractions an RNA-Bee (Tri-Test,
Inc) protocol was used. Synthesis of cDNA was performed
using Superscript III reverse transcriptase (Invitrogen, CA,
USA). To measure mRNA levels, qRT-PCR on cDNA samples
was carried out using an SYBRw select Master Mix for CFX
(Applied Biosystems, Inc., USA). All samples were analyzed on
the Bio-Rad CFX96 qPCR detection system.
Primers used for qRT-PCR were designed using Primer3Plus
tool (80). Primers for the reference genes sdha and b-actin were
designed using Primer Express software (version 2.0.0). Oligo-
nucleotide sequences are shown in detail in Supplementary
Material, Table S1.
Eye measurements
WTandmorphant embryos at 5 dpfwere euthanized and fixed in
4%paraformaldehyde at 48Covernight. Photographsweremade
at a fixed magnification of the dorsal view of the whole embryo
with a camera (Olympus DP72) attached to a dissecting micro-
scope (Olympus SZX 16). The cellSense imaging software
(Olympus) was used to measure eye, head and body length for
each embryo. Eye length was defined as the longest dimension
of the elliptical eye, head length was determined from the most
anterior part of the head to the otic vesicles, as previously
described (81) and body length was measured from the tip of
the head to the end of the trunk. The ratio of the eye size to
body length (E:B) was measured to determine the relative size
of the eye (40). The ratio of the eye size to head length (E:H)
was measured to evaluate the effect of six6b depletion on eye
size, independently of the head length.
For the assessment of the rescue experiments, three eye mea-
surements from the dorsal view of embryos at 3 pdf were made.
First, the eye length (defined previously) and called anterior–
posterior length (AP), second the superior–inferior (SI) length
defined as the longest dimension along the superior–inferior
axis and third the total eye area. All measurements were traced
using the Count & Measure function of the cellSense imaging
software.
Histological analysis
Histological analysis was performed using standard protocols.
Briefly, embryos were fixed in 4% paraformaldehyde at 48C
overnight, embedded in paraffin using standard procedures and
cut in 6 mm sections. Subsequently, histological hematoxylin–
eosin staining of the sections was carried out using a standard
protocol.
Immunohistochemistry
Briefly, deparaffinnized sections were pretreated for antigen re-
trieval by microwave heating in 0.1 m sodium citrate buffer (ph
6) for time series of 9-3-3 min. Expression pattern of six6 in
larvae at 3 dpf was evaluated using a rabbit polyclonal antibody
against six6 (1:400, Sigma). Proliferating cells were labeled
using a mouse monoclonal antibody to PCNA (1:32000,
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Sigma). All antibody incubations were carried out overnight at
48C followed by incubation with a secondary antibody (Bright-
Vision Poly-HRP-anti-rabbit IgG or poly-HRP-Anti-mouse,
respectively) and indirect immunoperoxidase labeling and
hematoxylin counter stain was performed.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
ACKNOWLEDGEMENTS
For the RS, we thank Ada Hooghart, Corina Brussee, Riet
Bernaerts-Biskop and Patricia van Hilten for the ophthalmic
data collection; Pascal Arp, Mila Jhamai, Marijn Verkerk, for
their help in creating the GWAS database; Carolina Medina-
Gomez and Fernando Rivadeneira for their support in creation
of 1000 genomes imputed data. The authors are grateful to the
study participants, the staff from the RS and the participating
general practitioners and pharmacists. For the ERF study, we
are grateful to all participants and their relatives, to general prac-
titioners andneurologists for their contributions, toP.Veraart for
her help in genealogy, to JeannetteVergeer for the supervisionof
the laboratory work, to P. Snijders for his help in data collection
and to Elisa van Leeuwen, Maarten Kooijman and Lennart
Karssen for their support in creation of 1000 genomes imputed
data.
Conflict of Interest statement. None declared.
FUNDING
This study was supported by Stichting Lijf en Leven. The ERF
study was supported by grants from the Netherlands Organiza-
tion for Scientific Research (NWO) and a joint grant from
NWO and the Russian Foundation for Basic research (Pionier,
047.016.009, 047.017.043), Erasmus Medical Center, and the
Centre for Medical Systems Biology (CMSB; National Genom-
ics Initiative). Exome sequencing analysis inERFwas supported
by the ZonMw grant (91111025). The generation and manage-
ment of GWAS genotype data for the RS is supported by the
Netherlands Organization for Scientific Research NWO Invest-
ments (nr. 175.010.2005.011, 911-03-012). This study is funded
by the Research Institute for Diseases in the Elderly
(014-93-015; RIDE2); the Netherlands Genomics Initiative
Netherlands Organization for Scientific Research (NWO)
(project nr. 050-060-810); CHANCES (nr 242244). The RS is
funded by Erasmus Medical Center and Erasmus University,
Rotterdam, Netherlands Organization for the Health Research
and Development (ZonMw), the Research Institute for Diseases
in the Elderly (RIDE), the Ministry of Education, Culture and
Science, the Ministry for Health, Welfare and Sports, the Euro-
peanCommission (DGXII), and theMunicipality of Rotterdam;
M.D. Fonds; Stichting Oogfonds Nederland; Henkes Stichting;
Stichting Nederlands Oogheelkundig Onderzoek; Swart van
Essen; Bevordering van Volkskracht; Blindenhulp; Landelijke
Stichting voor Blinden en Slechtzienden; Rotterdamse Vereni-
ging voor Blindenbelangen; OOG; Algemene Nederlandse Ver-
eniging ter Voorkoming van Blindheid; the Rotterdam Eye
Hospital Research Foundation; Medical Workshop; Heidelberg
Engineering; Topcon Europe BV.
REFERENCES
1. Kwon, Y.H., Fingert, J.H., Kuehn, M.H. and Alward, W.L. (2009) Primary
open-angle glaucoma. N. Engl. J. Med., 360, 1113–1124.
2. Ramdas, W.D., Amin, N., van Koolwijk, L.M., Janssens, A.C., Demirkan,
A., de Jong,P.T.,Aulchenko,Y.S.,Wolfs,R.C.,Hofman,A.,Rivadeneira,F.
et al. (2011) Genetic architecture of open angle glaucoma and related
determinants. J. Med. Genet., 48, 190–196.
3. Ramdas,W.D.,Wolfs, R.C., Hofman,A., de Jong, P.T., Vingerling, J.R. and
Jansonius, N.M. (2011) Lifestyle and risk of developing open-angle
glaucoma: the Rotterdam study. Arch. Ophthalmol., 129, 767–772.
4. Ramdas,W.D.,Wolfs, R.C., Hofman,A., de Jong, P.T., Vingerling, J.R. and
Jansonius, N.M. (2011) Ocular perfusion pressure and the incidence of
glaucoma: real effect or artifact? The Rotterdam Study. Invest. Ophthalmol.
Vis. Sci., 52, 6875–6881.
5. Wolfs, R.C., Klaver, C.C., Ramrattan, R.S., van Duijn, C.M., Hofman, A.
and de Jong, P.T. (1998) Genetic risk of primary open-angle glaucoma.
Population-based familial aggregation study. Arch. Ophthalmol., 116,
1640–1645.
6. Schwartz, J.T.,Reuling, F.H. andFeinleib,M. (1975)Size of the physiologic
cup of the optic nerve head. hereditary and environmental factors. Arch.
Ophthalmol., 93, 776–778.
7. Freeman, E.E., Roy-Gagnon, M.H., Descovich, D., Masse, H. and Lesk,
M.R. (2013) The heritability of glaucoma-related traits corneal hysteresis,
central corneal thickness, intraocular pressure, and choroidal blood flow
pulsatility. PLoS One, 8, e55573.
8. Klein, B.E., Klein, R. and Lee, K.E. (2004) Heritability of risk factors for
primary open-angle glaucoma: the Beaver Dam Eye Study. Invest.
Ophthalmol. Vis. Sci., 45, 59–62.
9. van Koolwijk, L.M., Despriet, D.D., van Duijn, C.M., Pardo Cortes, L.M.,
Vingerling, J.R., Aulchenko, Y.S., Oostra, B.A., Klaver, C.C. and Lemij,
H.G. (2007) Genetic contributions to glaucoma: heritability of intraocular
pressure, retinal nerve fiber layer thickness, and optic disc morphology.
Invest. Ophthalmol. Vis. Sci., 48, 3669–3676.
10. Stone, E.M., Fingert, J.H., Alward, W.L., Nguyen, T.D., Polansky, J.R.,
Sunden, S.L., Nishimura, D., Clark, A.F., Nystuen, A., Nichols, B.E. et al.
(1997) Identification of a gene that causes primary open angle glaucoma.
Science, 275, 668–670.
11. Rezaie, T., Child, A., Hitchings, R., Brice, G., Miller, L., Coca-Prados, M.,
Heon, E., Krupin, T., Ritch, R., Kreutzer, D. et al. (2002) Adult-onset
primary open-angle glaucoma caused by mutations in optineurin. Science,
295, 1077–1079.
12. Monemi, S., Spaeth, G., DaSilva, A., Popinchalk, S., Ilitchev, E., Liebmann,
J., Ritch, R., Heon, E., Crick, R.P., Child, A. et al. (2005) Identification of a
novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1.
Hum. Mol. Genet., 14, 725–733.
13. Wiggs, J.L.,Kang, J.H.,Yaspan,B.L.,Mirel,D.B.,Laurie,C.,Crenshaw,A.,
Brodeur, W., Gogarten, S., Olson, L.M., Abdrabou, W. et al. (2011)
Common variants near CAV1 and CAV2 are associated with primary
open-angle glaucoma in Caucasians from the USA. Hum. Mol. Genet., 20,
4707–4713.
14. Thorleifsson, G., Walters, G.B., Hewitt, A.W., Masson, G., Helgason, A.,
DeWan, A., Sigurdsson, A., Jonasdottir, A., Gudjonsson, S.A., Magnusson,
K.P. et al. (2010) Common variants near CAV1 and CAV2 are associated
with primary open-angle glaucoma. Nat. Genet., 42, 906–909.
15. Burdon, K.P.,Macgregor, S., Hewitt, A.W., Sharma, S., Chidlow, G.,Mills,
R.A., Danoy, P., Casson, R., Viswanathan, A.C., Liu, J.Z. et al. (2011)
Genome-wide association study identifies susceptibility loci for open angle
glaucoma at TMCO1 and CDKN2B-AS1. Nat. Genet., 43, 574–578.
16. Ramdas,W.D., vanKoolwijk, L.M., Ikram,M.K., Jansonius,N.M., de Jong,
P.T., Bergen,A.A., Isaacs, A., Amin,N., Aulchenko, Y.S.,Wolfs, R.C. et al.
(2010) A genome-wide association study of optic disc parameters. PLoS
Genet., 6, e1000978.
17. Ramdas, W.D., van Koolwijk, L.M., Lemij, H.G., Pasutto, F., Cree, A.J.,
Thorleifsson, G., Janssen, S.F., Jacoline, T.B., Amin, N., Rivadeneira, F.
et al. (2011) Common genetic variants associated with open-angle
glaucoma. Hum. Mol. Genet., 20, 2464–2471.
1330 Human Molecular Genetics, 2014, Vol. 23, No. 5
 at Institute of Social Studies on M
ay 17, 2016
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
18. Brown,N.L., Patel, S., Brzezinski, J. andGlaser, T. (2001)Math5 is required
for retinal ganglion cell and optic nerve formation. Development, 128,
2497–2508.
19. Mao, C.A., Cho, J.H.,Wang, J., Gao, Z., Pan, P., Tsai,W.W., Frishman, L.J.
and Klein, W.H. (2013) Reprogramming amacrine and photoreceptor
progenitors into retinal ganglion cells by replacing Neurod1 with Atoh7.
Development, 140, 541–551.
20. Prasov, L., Nagy, M., Rudolph, D.D. and Glaser, T. (2012) Math5 (Atoh7)
gene dosage limits retinal ganglion cell genesis.Neuroreport, 23, 631–634.
21. Jean, D., Bernier, G. and Gruss, P. (1999) Six6 (Optx2) is a novel murine
Six3-related homeobox gene that demarcates the presumptive pituitary/
hypothalamic axis and the ventral optic stalk. Mech. Dev., 84, 31–40.
22. Gallardo, M.E., Lopez-Rios, J., Fernaud-Espinosa, I., Granadino, B., Sanz,
R., Ramos, C., Ayuso, C., Seller, M.J., Brunner, H.G., Bovolenta, P. et al.
(1999) Genomic cloning and characterization of the human homeobox gene
SIX6 reveals a cluster of SIX genes in chromosome 14 and associates SIX6
hemizygosity with bilateral anophthalmia and pituitary anomalies.
Genomics, 61, 82–91.
23. Boucher, C.A., Carey, N., Edwards, Y.H., Siciliano, M.J. and Johnson, K.J.
(1996) Cloning of the human SIX1 gene and its assignment to chromosome
14. Genomics, 33, 140–142.
24. Ridgeway, A.G. and Skerjanc, I.S. (2001) Pax3 is essential for skeletal
myogenesis and the expression of Six1 and Eya2. J. Biol. Chem., 276,
19033–19039.
25. Serikaku, M.A. and O’Tousa, J.E. (1994) Sine oculis is a homeobox gene
required for Drosophila visual system development. Genetics, 138, 1137–
1150.
26. Oliver, G.,Mailhos, A.,Wehr, R., Copeland, N.G., Jenkins, N.A. andGruss,
P. (1995) Six3, a murine homologue of the sine oculis gene, demarcates the
most anterior border of the developing neural plate and is expressed during
eye development. Development, 121, 4045–4055.
27. Fan, B.J., Wang, D.Y., Pasquale, L.R., Haines, J.L. and Wiggs, J.L. (2011)
Genetic variants associated with optic nerve vertical cup-to-disc ratio are
risk factors for primary open angle glaucoma in a US Caucasian population.
Invest. Ophthalmol. Vis. Sci., 52, 1788–1792.
28. Cao, D., Jiao, X., Liu, X., Hennis, A., Leske, M.C., Nemesure, B. and
Hejtmancik, J.F. (2012)CDKN2Bpolymorphism is associatedwith primary
open-angle glaucoma (POAG) in the Afro-Caribbean population of
Barbados, West Indies. PLoS One, 7, e39278.
29. Pasquale, L.R., Loomis, S.J., Kang, J.H., Yaspan, B.L., Abdrabou, W.,
Budenz, D.L., Chen, T.C., Delbono, E., Friedman, D.S., Gaasterland, D.
et al. (2013) CDKN2B-AS1 genotype-glaucoma feature correlations in
primary open-angle glaucoma patients from the United States.
Am. J. Ophthalmol., 155, 342–353 e345.
30. Osman,W., Low,S.K., Takahashi,A.,Kubo,M. andNakamura,Y. (2012)A
genome-wide association study in the Japanese population confirms 9p21
and14q23as susceptibility loci for primaryopenangleglaucoma.Hum. Mol.
Genet., 21, 2836–2842.
31. Burdon,K.P., Crawford,A., Casson, R.J., Hewitt, A.W., Landers, J., Danoy,
P., Mackey, D.A., Mitchell, P., Healey, P.R. and Craig, J.E. (2012)
Glaucoma risk alleles at CDKN2B-AS1 are associated with lower
intraocular pressure, normal-tension glaucoma, and advanced glaucoma.
Ophthalmology, 119, 1539–1545.
32. Nakano, M., Ikeda, Y., Tokuda, Y., Fuwa, M., Omi, N., Ueno, M., Imai, K.,
Adachi, H., Kageyama, M., Mori, K. et al. (2012) Common variants in
CDKN2B-AS1 associated with optic-nerve vulnerability of glaucoma
identified by genome-wide association studies in Japanese. PLoS One, 7,
e33389.
33. Wiggs, J.L., Yaspan, B.L., Hauser, M.A., Kang, J.H., Allingham, R.R.,
Olson,L.M.,Abdrabou,W., Fan,B.J.,Wang,D.Y.,Brodeur,W. et al. (2012)
Common variants at 9p21 and 8q22 are associated with increased
susceptibility to optic nerve degeneration in glaucoma. PLoS Genet., 8,
e1002654.
34. Krimpenfort, P., Ijpenberg, A., Song, J.Y., van der Valk, M., Nawijn, M.,
Zevenhoven, J. and Berns, A. (2007) p15Ink4b is a critical tumour
suppressor in the absence of p16Ink4a. Nature, 448, 943–946.
35. Li, X., Perissi, V., Liu, F., Rose, D.W. and Rosenfeld, M.G. (2002)
Tissue-specific regulation of retinal and pituitary precursor cell
proliferation. Science, 297, 1180–1183.
36. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A.,
Bork, P., Kondrashov, A.S. and Sunyaev, S.R. (2010) A method and server
for predicting damaging missense mutations. Nat. Methods, 7, 248–249.
37. Cooper, G.M., Goode, D.L., Ng, S.B., Sidow,A., Bamshad,M.J., Shendure,
J. and Nickerson, D.A. (2010) Single-nucleotide evolutionary constraint
scores highlight disease-causing mutations. Nat. Methods, 7, 250–251.
38. Consortium, G.T. (2013) The Genotype-Tissue Expression (GTEx) project.
Nat. Genet., 45, 580–585.
39. Wagner, A.H., Anand, V.N., Wang, W.H., Chatterton, J.E., Sun, D.,
Shepard, A.R., Jacobson, N., Pang, I.H., Deluca, A.P., Casavant, T.L. et al.
(2013) Exon-level expression profiling of ocular tissues.Exp. Eye Res., 111,
105–111.
40. Veth, K.N., Willer, J.R., Collery, R.F., Gray, M.P., Willer, G.B., Wagner,
D.S., Mullins, M.C., Udvadia, A.J., Smith, R.S., John, S.W. et al. (2011)
Mutations in zebrafish lrp2 result in adult-onset ocular pathogenesis that
models myopia and other risk factors for glaucoma. PLoS Genet., 7,
e1001310.
41. Toy, J., Yang, J.M., Leppert, G.S. and Sundin, O.H. (1998) The optx2
homeobox gene is expressed in early precursors of the eye and activates
retina-specific genes. Proc. Natl. Acad. Sci. U S A., 95, 10643–10648.
42. Lopez-Rios, J., Gallardo,M.E., Rodriguez de Cordoba, S. and Bovolenta, P.
(1999) Six9 (Optx2), a new member of the six gene family of transcription
factors, is expressed at early stages of vertebrate ocular and pituitary
development. Mech. Dev., 83, 155–159.
43. Aijaz, S., Allen, J., Tregidgo, R., van Heyningen, V., Hanson, I. and Clark,
B.J. (2005) Expression analysis of SIX3 and SIX6 in human tissues reveals
differences in expression and a novel correlation between the expression of
SIX3 and the genes encoding isocitrate dehyhrogenase and cadherin 18.
Genomics, 86, 86–99.
44. Zhou, X., Hollemann, T., Pieler, T. and Gruss, P. (2000) Cloning and
expression of xSix3, the Xenopus homologue of murine Six3. Mech. Dev.,
91, 327–330.
45. Lagutin, O., Zhu, C.C., Furuta, Y., Rowitch, D.H., McMahon, A.P. and
Oliver, G. (2001) Six3 promotes the formation of ectopic optic vesicle-like
structures in mouse embryos. Dev. Dyn., 221, 342–349.
46. Carl, M., Loosli, F. and Wittbrodt, J. (2002) Six3 inactivation reveals its
essential role for the formation and patterning of the vertebrate eye.
Development, 129, 4057–4063.
47. Amato, M.A., Arnault, E. and Perron, M. (2004) Retinal stem cells in
vertebrates: parallels and divergences. Int. J. Dev. Biol., 48, 993–1001.
48. Raymond, P.A., Barthel, L.K., Bernardos, R.L. and Perkowski, J.J. (2006)
Molecular characterization of retinal stem cells and their niches in adult
zebrafish. BMC Dev. Biol., 6, 36.
49. Kassen, S.C., Thummel,R., Burket,C.T.,Campochiaro,L.A.,Harding,M.J.
andHyde,D.R. (2008)TheTg(ccnb1:EGFP) transgenic zebrafish line labels
proliferating cells during retinal development and regeneration. Mol. Vis.,
14, 951–963.
50. Gallardo, M.E., Rodriguez De Cordoba, S., Schneider, A.S., Dwyer, M.A.,
Ayuso, C. and Bovolenta, P. (2004) Analysis of the developmental SIX6
homeobox gene in patientswith anophthalmia/microphthalmia.Am. J. Med.
Genet. A, 129A, 92–94.
51. Aijaz, S., Clark, B.J., Williamson, K., van Heyningen, V., Morrison, D.,
Fitzpatrick, D., Collin, R., Ragge, N., Christoforou, A., Brown, A. et al.
(2004) Absence of SIX6 mutations in microphthalmia, anophthalmia, and
coloboma. Invest. Ophthalmol. Vis. Sci., 45, 3871–3876.
52. Zuber, M.E., Perron, M., Philpott, A., Bang, A. and Harris, W.A. (1999)
Giant eyes in Xenopus laevis by overexpression of XOptx2. Cell, 98, 341–
352.
53. Lieschke, G.J. and Currie, P.D. (2007) Animal models of human disease:
zebrafish swim into view. Nat. Rev. Genet., 8, 353–367.
54. Guo, S. (2004) Linking genes to brain, behavior and neurological diseases:
what can we learn from zebrafish? Genes Brain Behav., 3, 63–74.
55. Malicki, J., Neuhauss, S.C., Schier, A.F., Solnica-Krezel, L., Stemple, D.L.,
Stainier, D.Y., Abdelilah, S., Zwartkruis, F., Rangini, Z. and Driever, W.
(1996) Mutations affecting development of the zebrafish retina.
Development, 123, 263–273.
56. Neuhauss, S.C. (2003) Behavioral genetic approaches to visual system
development and function in zebrafish. J. Neurobiol., 54, 148–160.
57. Haffter, P., Granato, M., Brand, M., Mullins, M.C., Hammerschmidt, M.,
Kane, D.A., Odenthal, J., van Eeden, F.J., Jiang, Y.J., Heisenberg, C.P. et al.
(1996) The identification of genes with unique and essential functions in the
development of the zebrafish, Danio rerio. Development, 123, 1–36.
58. Cheyette, B.N., Green, P.J., Martin, K., Garren, H., Hartenstein, V. and
Zipursky, S.L. (1994) The Drosophila sine oculis locus encodes a
homeodomain-containing protein required for the development of the entire
visual system. Neuron, 12, 977–996.
Human Molecular Genetics, 2014, Vol. 23, No. 5 1331
 at Institute of Social Studies on M
ay 17, 2016
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
59. Kobayashi, M., Toyama, R., Takeda, H., Dawid, I.B. and Kawakami, K.
(1998) Overexpression of the forebrain-specific homeobox gene six3
induces rostral forebrain enlargement in zebrafish. Development, 125,
2973–2982.
60. Loosli, F.,Winkler, S. andWittbrodt, J. (1999) Six3 overexpression initiates
the formation of ectopic retina. Genes Dev., 13, 649–654.
61. Bernier, G., Panitz, F., Zhou, X., Hollemann, T., Gruss, P. and Pieler, T.
(2000) Expanded retina territory by midbrain transformation upon
overexpression of Six6 (Optx2) in Xenopus embryos. Mech. Dev., 93, 59–
69.
62. Del Bene, F., Tessmar-Raible, K. andWittbrodt, J. (2004)Direct interaction
of geminin and Six3 in eye development. Nature, 427, 745–749.
63. Lopez-Rios, J., Tessmar, K., Loosli, F., Wittbrodt, J. and Bovolenta, P.
(2003) Six3 and Six6 activity is modulated by members of the groucho
family. Development, 130, 185–195.
64. Dimasi,D.P., Burdon,K.P.,Hewitt,A.W., Fitzgerald, J.,Wang, J.J., Healey,
P.R.,Mitchell,P.,Mackey,D.A.andCraig, J.E. (2012)Genetic investigation
into the endophenotypic status of central corneal thickness and optic disc
parameters in relation to open-angle glaucoma. Am. J. Ophthalmol., 154,
833–842 e832.
65. Hannon, G.J. and Beach, D. (1994) p15INK4B is a potential effector of
TGF-beta-induced cell cycle arrest. Nature, 371, 257–261.
66. Gonzalez-Nunez, V., Nocco, V. and Budd, A. (2010) Characterization of
drCol 15a1b: a novel component of the stemcell niche in the zebrafish retina.
Stem Cells, 28, 1399–1411.
67. Agathocleous,M. andHarris,W.A. (2009) Fromprogenitors to differentiated
cells in the vertebrate retina. Annu. Rev. Cell Dev. Biol., 25, 45–69.
68. Hofman, A., van Duijn, C.M., Franco, O.H., Ikram, M.A., Janssen, H.L.,
Klaver, C.C., Kuipers, E.J., Nijsten, T.E., Stricker, B.H., Tiemeier, H. et al.
(2011) The Rotterdam Study: 2012 objectives and design update.
Eur. J. Epidemiol., 26, 657–686.
69. Aulchenko, Y.S., Heutink, P., Mackay, I., Bertoli-Avella, A.M., Pullen, J.,
Vaessen, N., Rademaker, T.A., Sandkuijl, L.A., Cardon, L., Oostra, B. et al.
(2004) Linkage disequilibrium in young genetically isolated Dutch
population. Eur. J. Hum. Genet., 12, 527–534.
70. Pardo, L.M., MacKay, I., Oostra, B., van Duijn, C.M. and Aulchenko, Y.S.
(2005) The effect of genetic drift in a young genetically isolated population.
Ann. Hum. Genet., 69, 288–295.
71. Rolando, M., Iester, M., Campagna, P., Borgia, L., Traverso, C. and
Calabria, G. (1994) Measurement variability in digital analysis of optic
discs. Doc. Ophthalmol., 85, 211–222.
72. Dielemans, I., Vingerling, J.R.,Wolfs,R.C.,Hofman,A., Grobbee,D.E. and
de Jong, P.T. (1994) The prevalence of primary open-angle glaucoma in a
population-based study in The Netherlands. The Rotterdam Study.
Ophthalmology, 101, 1851–1855.
73. Czudowska, M.A., Ramdas,W.D., Wolfs, R.C., Hofman, A., De Jong, P.T.,
Vingerling, J.R. and Jansonius, N.M. (2010) Incidence of glaucomatous
visual field loss: a ten-year follow-up from the Rotterdam Study.
Ophthalmology, 117, 1705–1712.
74. Li, H. and Durbin, R. (2009) Fast and accurate short read alignment with
Burrows–Wheeler transform. Bioinformatics, 25, 1754–1760.
75. Brouwer, R.W., van den Hout, M.C., Grosveld, F.G. and van Ijcken, W.F.
(2012) NARWHAL, a primary analysis pipeline for NGS data.
Bioinformatics, 28, 284–285.
76. McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K.,
Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M. et al.
(2010) The Genome Analysis Toolkit: a MapReduce framework for
analyzing next-generation DNA sequencing data. Genome Res., 20, 1297–
1303.
77. Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B. and Schilling,
T.F. (1995) Stages of embryonic development of the zebrafish. Dev. Dyn.,
203, 253–310.
78. Vilella,A.J., Severin, J.,Ureta-Vidal,A.,Heng,L.,Durbin,R. andBirney,E.
(2009) EnsemblCompara GeneTrees: complete, duplication-aware
phylogenetic trees in vertebrates. Genome Res., 19, 327–335.
79. Robu, M.E., Larson, J.D., Nasevicius, A., Beiraghi, S., Brenner, C., Farber,
S.A. and Ekker, S.C. (2007) p53 activation by knockdown technologies.
PLoS Genet., 3, e78.
80. Untergasser, A., Nijveen, H., Rao, X., Bisseling, T., Geurts, R. and
Leunissen, J.A. (2007) Primer3Plus, an enhanced web interface to Primer3.
Nucleic Acid Res., 35, W71–W74.
81. van de Water, S., van de Wetering, M., Joore, J., Esseling, J., Bink, R.,
Clevers, H. and Zivkovic, D. (2001) Ectopic Wnt signal determines the
eyeless phenotype of zebrafish masterblind mutant. Development, 128,
3877–3888.
1332 Human Molecular Genetics, 2014, Vol. 23, No. 5
 at Institute of Social Studies on M
ay 17, 2016
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
